chartexchange

Mesoblast Showcased at ASX Premier Investor Day Event

GlobeNewswire Inc. | Nov 15, 2026 6:16 PM EST

NEW YORK, Nov. 15, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it was highlighted at the Australian Securities Exchange (ASX) Investor Day in Melbourne at the session titled “Meet the CEO: Inside Australia’s Listed Companies.”

Read original article